B.Riley Financial analyst William Wood has reiterated their bullish stance on IMUX stock, giving a Buy rating on September 16. William Wood ...

Systemic sclerosis is an autoimmune disease that primarily causes inflammation of the skin, as well as internal organs such ...

Although multiple sclerosis (MS) and muscular dystrophy (MD) are both debilitating diseases that may seem similar, they are ...

A short course of Mavenclad can provide long-term reductions in disease activity and disability progression in highly active ...

As usual, a second trial will be needed before UCB and Biogen can file dapirolizumab pegol with regulators. It will be called ...

Sanofi's chief executive, Paul Hudson, said in an interview on Monday that the company is poised for strong growth from a ...

[10] Conti P, Kempuraj D. Important role of mast cells in multiple sclerosis. Mult Scler Relat Disord. 2016;5:77-80. [11] Skaper SD, Facci L, Giusti P. Mast cells, glia and neuroinflammation: partners ...

Zenas BioPharma, which is developing immunology-based therapies, said on Friday it is targeting a valuation of as much as ...

Biogen markets several multiple sclerosis drugs including Plegridy ... Biogen has several drug candidates in phase 3 trials ...

Highly effective MS treatments like monoclonal antibodies and immune-suppressing drugs “may lead to better clinical outcomes ...

“If not treated early upon diagnosis, multiple sclerosis can lead to significant ... senior vice president and head of clinical development, Immunology, Cardiovascular and Neuroscience, Bristol Myers ...

Today is an important day for Cardarelli as it inaugurates a department dedicated to patients with multiple sclerosis. We ...